宏细胞中RNAi的高效聚合物纳米颗粒揭示了STAT3/STAT6被击倒后对极化标记物的复杂影响
Maximilian Walther1, Robert Jenke1, Achim Aigner1
1Rudolf-Boehm-Institute for Pharmacology and Toxicology, Clinical Pharmacology, Leipzig University, Faculty of Medicine, Leipzig, Germany.
概括
将瘤相关巨细胞 (TAM) 从M2重编程到M1是一种有前途的癌症免疫疗法. 氨酸修饰的纳米颗粒有效地将siRNA传递给巨细胞,从而使STAT6倒退并增强抗瘤活性.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 瘤相关巨细胞 (TAMs) 是影响瘤进展和治疗反应的关键免疫细胞.
- TAM存在不同的激活状态 (M1:抗瘤,M2:亲瘤).
- 将M2 TAM重聚到M1是一种潜在的免疫疗法策略.
研究的目的:
- 评估纳米粒子系统,以有效地向巨细胞传递siRNA.
- 为了调查siRNA介导的基因敲除TAM再极化.
- 评估复极化对抗瘤活性的影响.
主要方法:
- 对基于PEI和PPI的纳米颗粒进行了测试,用于在巨细胞中传递siRNA.
- 使用氨酸修饰的纳米粒子 (LP10Y,P5Y,PPI-Y) 进行基因淘汰.
- 分析了M2/M1标记物变化和STAT6/STAT3倒置效应.
- 在共同培养模型中评估瘤细胞化.
主要成果:
- 用氨酸修饰的PEI和PPI纳米颗粒在巨细胞的基因淘汰中表现出高效率.
- STAT6或STAT3倒置诱导的M2到M1再极化.
- 通过PPI-Y/siRNA增强瘤细胞的巨细胞细胞酶.
- 确定了STAT3和STAT6在巨细胞再极化中的非冗余作用.
结论:
- 特定的氨酸修饰PEI/PPI纳米颗粒对巨细胞转染是有效的.
- 通过siRNA介导的STAT6淘汰是TAM再极化的一个有前途的方法.
- 再极化巨细胞表现出增强的瘤细胞抑制功能.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


